mimosine has been researched along with dinoprost in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Fujita, K; Kainuma, S; Kozawa, O; Kuroyanagi, G; Matsushima-Nishiwaki, R; Ohguchi, R; Otsuka, T; Tokuda, H; Yamamoto, N | 1 |
2 other study(ies) available for mimosine and dinoprost
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Mimosine suppresses the PGF2α-induced synthesis of osteoprotegerin but not interleukin-6 in osteoblasts.
Topics: Animals; Cell Differentiation; Cell Line; Deferoxamine; Dinoprost; Gene Expression Regulation, Developmental; Hypoxia-Inducible Factor 1; Interleukin-6; MAP Kinase Kinase 4; Mice; Mimosine; Osteoblasts; Osteoprotegerin; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; RNA, Messenger; Transcription Factors; Tumor Suppressor Protein p53 | 2016 |